Huaxia Eye Hospital Group Co.,Ltd. Stock: price and insider trades · China
华厦眼科
1 insider bought €468k of shares over the last 90 days, the latest by 苏庆灿, filed 15 Sept 2026.
Huaxia Eye Hospital Group Co.,Ltd.: what insiders have been doing
Huaxia Eye Hospital Group Co.,Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). In the past year (6 November 2025 to 6 November 2026), 3 filings came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €468k, made by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €192k, bought by 苏庆灿 and made public on 15 September 2026. Those buying include 1 board member.
The most recent open-market purchase was published on 15 September 2026, 54 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (522 companies, median 2 filings), a count of 3 filings is above the norm. The full history, which starts in 2022, counts 3 purchases against 1 sale.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +5.4%Entry CN¥14.71 · Close 05 Nov 2026 CN¥15.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 101,000 shares@ CN¥113.779541.0% of flowA股XSHESZSE:273000001526544060Canonical exit: 14 Dec 2026 (T+90)
- 84,900 shares@ CN¥114.050434.2% of flowA股XSHESZSE:273000001503486700Canonical exit: 13 Dec 2026 (T+90)
- 60,000 shares@ CN¥117.787624.8% of flowA股XSHESZSE:273000001479713950Canonical exit: 8 Dec 2026 (T+90)
- 4,000 shares100.0% of flowA股XSHESZSE:173000006124545060
4 of 4 declarations
About Huaxia Eye Hospital Group Co.,Ltd.
华厦眼科 is a company specializing in the healthcare and pharmaceutical sector, focusing on eye care. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
